1. Home
  2. TGT vs TAK Comparison

TGT vs TAK Comparison

Compare TGT & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Corporation

TGT

Target Corporation

N/A

Current Price

$120.08

Market Cap

43.7B

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$18.08

Market Cap

56.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TGT
TAK
Founded
1902
1781
Country
United States
Japan
Employees
N/A
47455
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.7B
56.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
TGT
TAK
Price
$120.08
$18.08
Analyst Decision
Buy
Analyst Count
28
0
Target Price
$117.42
N/A
AVG Volume (30 Days)
5.6M
2.4M
Earning Date
06-02-2026
01-01-0001
Dividend Yield
3.77%
2.95%
EPS Growth
N/A
N/A
EPS
5.84
N/A
Revenue
$72,618,000,000.00
N/A
Revenue This Year
$2.80
$0.04
Revenue Next Year
$3.02
$0.92
P/E Ratio
$20.61
$41.25
Revenue Growth
1.88
N/A
52 Week Low
$83.44
$12.99
52 Week High
$126.00
$18.82

Technical Indicators

Market Signals
Indicator
TGT
TAK
Relative Strength Index (RSI) 62.46 53.16
Support Level $93.23 $14.78
Resistance Level N/A $18.82
Average True Range (ATR) 3.57 0.25
MACD 0.13 -0.17
Stochastic Oscillator 58.93 42.72

Price Performance

Historical Comparison
TGT
TAK

About TGT Target Corporation

Target's start dates back to 1962, but now it is one of the largest discount retailers in the United States (where it derives all of its sales), operating just under 2,000 stores and generating over $106 billion in fiscal 2024 sales. The company offers a broad assortment of merchandise across categories including apparel and accessories (16% of fiscal 2024 revenue), beauty and household essentials (30%), food and beverage (23%), hardlines (15%), as well as home furnishings (16%). Target's model is anchored in its physical store base, which fulfills more than 97% of sales. Around 30% of sales are derived from its own private-label brands.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Share on Social Networks: